The Spanish Agency for Medicines and Health Products (AEMPS)  has warned Panama’s Ministry of Health (MINSA) that the products containing the active ingredient of, Valsartan have an impurity and can be dangerous.

"The impurity has been generated as a result of a change in the manufacturing process of the valsartan raw material used by several pharmaceutical laboratories," reports the Ministry of Health.

Given the existing concern, Minsa consulted with the Database of Health Registries in the National Directorate of Pharmacy and Drugs, to confirm that no laboratory has received any health reports linked to the ingredient.

However, it is recommended that if you have medication with Valsartan you go to the doctor before any complication develops.